Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Fuji
Julphar
Farmers Insurance
Boehringer Ingelheim
Merck
Covington
Colorcon
Accenture

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,621,891

« Back to Dashboard

Summary for Patent: 7,621,891
Title:Method and apparatus for delivering epinephrine
Abstract:A method of administering liquid medicine such as epinephrine to a patient includes administering a first dose followed by administering an optional second dose is described herein. Also described herein are devices useful for carrying out the methods described and kits containing these devices.
Inventor(s): Wyrick; Ronald (Spokane, WA)
Assignee: Washington Biotech Corporation (Spokane, WA)
Application Number:11/276,460
Patent Claim Types:
see list of patent claims
Formulation; Delivery; Device;

Drugs Protected by US Patent 7,621,891

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Impax Labs Inc TWINJECT 0.15 epinephrine INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS 020800-002 May 28, 2004 DISCN No No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Impax Labs Inc TWINJECT 0.3 epinephrine INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS 020800-001 May 30, 2003 DISCN No No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 7,621,891

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,927,303 Medicine injection devices and methods ➤ Sign Up
7,297,136 Medicine injection devices and methods ➤ Sign Up
8,187,224 Methods performed by medicine injection apparatuses ➤ Sign Up
7,931,618 Apparatuses and methods for injecting medicines to a desired depth ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Moodys
Daiichi Sankyo
Deloitte
McKesson
Chinese Patent Office
Mallinckrodt
US Army
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.